New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Appay V, Jandus C, Voelter V, Reynard S, Coupland SE, Rimoldi D, Lienard D, Guillaume P, Krieg AM, Cerottini JC, Romero P, Leyvraz S, Rufer N, Speiser DE.
Appay V, et al. Among authors: romero p.
J Immunol. 2006 Aug 1;177(3):1670-8. doi: 10.4049/jimmunol.177.3.1670.
J Immunol. 2006.
PMID: 16849476